The Hydrocell technology enables hydration and maintains the volume of cells on the eye’s surface, preventing tears from evaporating ... Lens Solution by Bausch & Lomb. We have been using ...
LINE FRIENDS, the fan favorite global character brand known corporately as IPX, is teaming up with interactive entertainment brand HoYoverse, the developer of the beloved game Genshin Impact, to debut ...
Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...
Barclays raised the firm’s price target on Bausch + Lomb (BLCO) to $19 from $18 and keeps an Equal Weight rating on the shares. The firm says ...
Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...
City Therapeutics will develop a novel RNAi clinical candidate toward a specific disease target for intravitreal ...
The global vision care products market is projected to reach USD 103.7 billion by 2032, growing at a CAGR of 6.21%. This growth ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) today and set a price target ...
City Therapeutics and Bausch + Lomb have entered into a strategic collaboration focused on the development of an RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback